Literature DB >> 12960719

Natural history and clinical behavior of Crohn's disease extending beyond two decades.

Hugh James Freeman1.   

Abstract

Crohn's disease is a heterogeneous inflammatory disorder characterized by strictures or perforating complications. Information on natural history is limited. In the present study, 150 patients with long-standing Crohn's disease, including 81 females and 69 males, were seen continuously by a single clinician for at least 20 years. Additional retrospective data were available extending for >40 years and 13 have now died, usually with an advanced malignancy. To evaluate disease expression, phenotypic clinical characteristics defined by the 1998 Vienna classification for Crohn's disease were used and included age at diagnosis, location of disease, and disease behavior at the time of diagnosis or 10 years or 20 years after diagnosis. Most patients were initially diagnosed before the age of 40 years (94%) and had ileocolonic disease (65.3%). At diagnosis, both females and males were most often classified with inflammatory disease (nonstenosing, nonpenetrating); however, over the course of the disease, particularly in the first decade, decreased numbers of patients with inflammatory disease and increased numbers with penetrating disease were seen. In addition, some with stenosing disease eventually developed penetrating disease. Disease localized to ileum alone was most often complicated by stricture formation, whereas ileocolonic disease was usually complicated by a penetrating complication. This shift in disease behavior indicates that Crohn's disease is a dynamic process that phenotypically evolves and progresses with time.

Entities:  

Mesh:

Year:  2003        PMID: 12960719     DOI: 10.1097/00004836-200309000-00005

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  33 in total

1.  Endoscopy in inflammatory bowel disease when and why.

Authors:  Rajaratnam Rameshshanker; Naila Arebi
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

Review 2.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

3.  Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

4.  Granuloma-positive Crohn's disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

5.  Use of the Crohn's disease activity index in clinical trials of biological agents.

Authors:  Hugh-J Freeman
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

6.  Long-term natural history of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

7.  Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1.

Authors:  Y Motomura; W I Khan; R T El-Sharkawy; M Verma-Gandhu; E F Verdu; J Gauldie; S M Collins
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

8.  Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.

Authors:  Rong Fan; Jie Zhong; Zheng-Ting Wang; Shu-Yi Li; Jie Zhou; Yong-Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

9.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

10.  Effect of infliximab on small bowel stenoses in patients with Crohn's disease.

Authors:  Nadia Pallotta; Fausto Barberani; Naima-Abdulkadir Hassan; Danila Guagnozzi; Giuseppina Vincoli; Enrico Corazziari
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.